LUND,
Sweden, May 6, 2023 /PRNewswire/ --
Philipp von Hugo, member of the
board of directors of Immunovia AB (publ) ("Immunovia" or the
"Company"), has at his own request notified his resignation from
the Board of Directors of the Company and therefore declines
re-election at annual general meeting on 26
May 2023.
Philipp von Hugo, who has served
as board member of Immunovia since the annual general meeting in
2022, has on 5 May 2023 at his own
request with immediate effect, notified his resignation from his
position as board member of Immunovia and consequently declines
re-election, at the annual general meeting on 26 May 2023.
The Nomination Committee of the Company has been informed of his
decision.
"We thank Philipp for his commitment to the board and wish him
the best in his future engagements", comments the chair of the
Board of Directors Carl
Borrebaeck.
FOR MORE INFORMATION, PLEASE CONTACT:
Carl Borrebaeck
Chair of the Board of Directors
carl.borrebaeck@immun.lth.se
+46 70 821 83 30
Karin Almqvist Liwendahl
Chief Financial Officer
karin.almqvist.liwendahl@immunovia.com
+46 709 11 56 08
ABOUT IMMUNOVIA
Immunovia AB is a diagnostic company with the vision to
revolutionize blood-based diagnostics and increase survival rates
for patients with cancer. The company is headquartered in
Lund, Sweden. Immunovia's shares
are listed on Nasdaq Stockholm. For more information please visit
www.immunovia.com.
The following files are available for download:
|
https://mb.cision.com/Main/13121/3765124/2038906.pdf
|
Press release
(PDF)
|
View original
content:https://www.prnewswire.com/news-releases/the-board-member-philipp-von-hugo-resigns-from-immunovias-board-at-his-own-request-301817695.html
SOURCE Immunovia AB